Tag
Alembic Pharmaceuticals Limited
6 articles
Alembic Pharma: Chirayu Amin Appointed Executive Chairman
Mr. Chirayu Amin (DIN: 00242549) appointed as Executive Chairman of Alembic Pharmaceuticals effective 1st April, 2026 for 5 years.
Appointment was approved by shareholders at the 15th AGM held on 5th
Alembic Pharma Pranav Amin MD Re-appointment Effective
Alembic Pharmaceuticals intimates BSE and NSE of Pranav Amin's Managing Director re-appointment effective 1st April 2026.
Shareholders approved the re-appointment at the 15th AGM on 5th August 2025 fo
Alembic Pharma Appoints Rajkumar Baheti as Director
Alembic Pharmaceuticals appointed Mr. Rajkumar Baheti (DIN: 00332079) as Non-Executive Non-Independent Director effective 1st April, 2026.
Shareholders approved the appointment via Postal Ballot dated
Alembic Pharma Senior Manager Nilesh Wadhwa Resigns
Alembic Pharmaceuticals disclosed resignation of Mr. Nilesh Wadhwa, Head – Formulation Business Development, effective 31st March, 2026.
Resignation was originally submitted on 16th December 2025 and
Alembic Pharma Postal Ballot: Baheti Appointment Approved
Alembic Pharmaceuticals filed Postal Ballot voting results under Regulation 44(3) of SEBI LODR Regulations, 2015 dated March 31, 2026.
Both resolutions — appointment and professional fee payment for M
Alembic Pharma Gets USFDA Approval Paroxetine ER Tablets
Alembic Pharmaceuticals received USFDA final approval for Paroxetine Extended-Release Tablets USP, 12.5 mg on 27th March 2026.
The approved sANDA is therapeutically equivalent to Paxil CR Tablets 12.5